Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34(+) selected graft Research Letter

   

Authors:	Lin, R. J.; Sanchez, M.; Abbi, K.; Devlin, S. M.; Jakubowski, A. A.; Papadopoulos, E. B.; Barker, J. N.; Tamari, R.; Young, J. W.; Gyurkocza, B.; Ponce, D. M.; Dahi, P. B.; Maloy, M. A.; Giralt, S. A.; Perales, M. A.; Castro-Malaspina, H.
Title:	Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34(+) selected graft
Keywords:	adult; clinical article; treatment outcome; aged; survival rate; chronic myelomonocytic leukemia; busulfan; fludarabine; letter; cd34 antigen; incidence; melphalan; hematopoietic stem cell transplantation; risk factor; thiotepa; disease severity; nonmyeloablative conditioning; whole body radiation; long term care; remission; clinical effectiveness; thymocyte antibody; human; male; female; priority journal; patient risk
Journal Title:	Bone Marrow Transplantation
Volume:	55
Issue:	8
ISSN:	0268-3369
Publisher:	Nature Publishing Group
Date Published:	2020-08-01
Start Page:	1632
End Page:	1634
Language:	English
DOI:	10.1038/s41409-019-0723-x
PUBMED:	31645667
PROVIDER:	scopus
PMCID:	PMC7176517
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074202111&doi=10.1038%2fs41409-019-0723-x&partnerID=40&md5=1f999dbd5801c7be03856310a09a7bb6
Notes:	Letter -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/169910